Osteoclasts are not a source of SLIT3

Abstract

The axon guidance cue SLIT3 was identified as an osteoanabolic agent in two recent reports. However, these reports conflict in their nomination of osteoblasts versus osteoclasts as the key producers of skeletal SLIT3 and additionally offer conflicting data on the effects of SLIT3 on osteoclastogenesis. Here, aiming to address this discrepancy, we found no observable SLIT3 expression during human or mouse osteoclastogenesis and the only modest SLIT3-mediated effects on osteoclast differentiation. Conditional deletion of SLIT3 in cathepsin K (CTSK)-positive cells, including osteoclasts, had no effect on the number of osteoclast progenitors, in vitro osteoclast differentiation, overall bone mass, or bone resorption/formation parameters. Similar results were observed with the deletion of SLIT3 in LysM-positive cells, including osteoclast lineage cells. Consistent with this finding, bone marrow chimeras made from Slit3 ^−/− donors that lacked SLIT3 expression at all stages of osteoclast development displayed normal bone mass relative to controls. Taken in context, multiple lines of evidence were unable to identify the physiologic function of osteoclast-derived SLIT3, indicating that osteoblasts are the major source of skeletal SLIT3.

References

[1] Black DM, Rosen CJ. Postmenopausal Osteoporosis. N. Engl. J. Med., 2016, 374:2096-2097

[2] Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N. Engl. J. Med., 2007, 357:905-916

[3] Xu R. Semaphorin 3A: a new player in bone remodeling. Cell Adh. Migr., 2014, 8:5-10

[4] Fukuda T et al. Sema3A regulates bone-mass accrual through sensory innervations. Nature, 2013, 497:490-493

[5] Negishi-Koga T et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat. Med., 2011, 17:1473-1480

[6] Zhu S et al. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J. Clin. Investig., 2019, 129:1076-1093

[7] Tumelty KE et al. Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways. J. Biol. Chem., 2018, 293:3039-3055

[8] Xu R et al. Targeting skeletal endothelium to ameliorate bone loss. Nat. Med., 2018, 24:823-833

[9] Kim BJ et al. Osteoclast-secreted SLIT3 coordinates bone resorption and formation. J. Clin. Investig., 2018, 128:1429-1441

[10] Long H et al. Conserved roles for Slit and Robo proteins in midline commissural axon guidance. Neuron, 2004, 42:213-223

[11] Geutskens SB, Hordijk PL, van Hennik PB. The chemorepellent Slit3 promotes monocyte migration. J. Immunol., 2010, 185:7691-7698

[12] Geutskens SB et al. Control of human hematopoietic stem/progenitor cell migration by the extracellular matrix protein Slit3. Lab Investig., 2012, 92:1129-1139

[13] Dickinson RE et al. Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. Br. J. Cancer, 2004, 91:2071-2078

[14] Greaves E et al. Estrogen receptor (ER) agonists differentially regulate neuroangiogenesis in peritoneal endometriosis via the repellent factor SLIT3. Endocrinology, 2014, 155:4015-4026

[15] Zhang B et al. Repulsive axon guidance molecule Slit3 is a novel angiogenic factor. Blood, 2009, 114:4300-4309

[16] Yuan W et al. A genetic model for a central (septum transversum) congenital diaphragmatic hernia in mice lacking Slit3. Proc. Natl Acad. Sci. USA, 2003, 100:5217-5222

[17] Paul JD et al. SLIT3-ROBO4 activation promotes vascular network formation in human engineered tissue and angiogenesis in vivo. J. Mol. Cell Cardiol., 2013, 64:124-131

[18] Lattin JE et al. Expression analysis of G Protein-Coupled Receptors in mouse macrophages. Immunome Res., 2008, 4

[19] Murata K et al. Hypoxia-sensitive COMMD1 integrates signaling and cellular metabolism in human macrophages and suppresses osteoclastogenesis. Immunity, 2017, 47:66-79 e65

[20] Tohmonda T et al. IRE1alpha/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis. J. Clin. Investig., 2015, 125:3269-3279

[21] Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res., 1999, 8:265-277

[22] Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J. Clin. Investig., 2013, 123:666-681

[23] Xie H et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat. Med., 2014, 20:1270-1278

[24] Greenblatt MB et al. CHMP5 controls bone turnover rates by dampening NF-kappaB activity in osteoclasts. J. Exp. Med., 2015, 212:1283-1301

[25] Debnath S et al. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature, 2018, 562:133-139

[26] Leder BZ et al. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet, 2015, 386:1147-1155

[27] Tsai JN et al. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet, 2013, 382:50-56

[28] Inoue K et al. Bone protection by inhibition of microRNA-182. Nat. Commun., 2018, 9

[29] Xu, R. et al. c-Jun N-terminal kinases (JNKs) are critical mediators of osteoblast activity in vivo. J. Bone Miner Res (2017).

[30] Dobin A et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics, 2013, 29:15-21

[31] Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics, 2014, 30:923-930

[32] Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 2014, 15

[33] Kusumbe AP, Ramasamy SK, Starsichova A, Adams RH. Sample preparation for high-resolution 3D confocal imaging of mouse skeletal tissue. Nat. Protoc., 2015, 10:1904-1914

[34] Zhao B et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat. Med., 2009, 15:1066-1071

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81972034)

Minjiang Scholar Professorship in Fujian Province and start-up grant from Xiamen University

U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(R01AR068970)